Bioadaptives (BDPT) Interest Expenses (2014 - 2026)

Bioadaptives has disclosed Interest Expenses across 11 years of filings, most recently posting $15561.0 for Q1 2026.

• Interest Expenses for Q1 2026 came in at $15561.0, up 61.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $76794.0 (up 1247.89% YoY), and the FY2025 annual result was $70880.0, up 85.17% from the prior year.
• Interest Expenses came in at $15561.0 for Q1 2026 at Bioadaptives, down from $37431.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $94106.0 in Q3 2022 to a low of -$80879.0 in Q4 2023.
• The 5-year median for Interest Expenses is $12425.0 (2022), against an average of $16293.6.
• Across the five-year window, Interest Expenses soared 376.01% in 2022 and plunged 803.36% in 2023, its largest moves.
• Bioadaptives' Interest Expenses stood at $11499.0 in 2022, then slumped by 803.36% to -$80879.0 in 2023, then jumped by 45.59% to -$44003.0 in 2024, then surged by 185.06% to $37431.0 in 2025, then sank by 58.43% to $15561.0 in 2026.
• The last three Interest Expenses figures came in at $15561.0 (Q1 2026), $37431.0 (Q4 2025), and $14153.0 (Q3 2025), per Business Quant data.